CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2007; 57:43-66
doi: 10.3322/canjclin.57.1.43
© 2007 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.

Cancer Statistics, 2007

Ahmedin Jemal, DVM,PhD, Rebecca Siegel, MPH, Elizabeth Ward, PhD, Taylor Murray, Jiaquan Xu and Michael J. Thun, MD,MS

Dr. Jemal is Strategic Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Xu is Analyst, Mortality Statistics Branch, Division of Vital Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.

This article is available online at http://CAonline.AmCancerSoc.org

Each year, the American Cancer Society (ACS) estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. This report considers incidence data through 2003 and mortality data through 2004. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,444,920 new cancer cases and 559,650 deaths for cancers are projected to occur in the United States in 2007. Notable trends in cancer incidence and mortality rates include stabilization of the age-standardized, delay-adjusted incidence rates for all cancers combined in men from 1995 through 2003; a continuing increase in the incidence rate by 0.3% per year in women; and a 13.6% total decrease in age-standardized cancer death rates among men and women combined between 1991 and 2004. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. While the absolute number of cancer deaths decreased for the second consecutive year in the United States (by more than 3,000 from 2003 to 2004) and much progress has been made in reducing mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
N. F. Esnaola, M. Gebregziabher, K. Knott, C. Finney, G. A. Silvestri, C. E. Reed, and M. E. Ford
Underuse of surgical resection for localized, non-small cell lung cancer among whites and african americans in South Carolina.
Ann. Thorac. Surg., July 1, 2008; 86(1): 220 - 227.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Sehouli, D. Stengel, G. Oskay-Oezcelik, A. G. Zeimet, H. Sommer, P. Klare, M. Stauch, A. Paulenz, O. Camara, E. Keil, et al.
Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
J. Clin. Oncol., July 1, 2008; 26(19): 3176 - 3182.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. J. Cohen, C. J.A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. Morse, E. Mitchell, M. C. Miller, et al.
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
J. Clin. Oncol., July 1, 2008; 26(19): 3213 - 3221.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Huang, R. Eisenberg, M. Yan, S. Monti, E. Lawrence, P. Fu, J. Walbroehl, E. Lowenberg, T. Golub, J. Merchan, et al.
15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3{beta} and a Tumor Suppressor in Lung Cancer
Cancer Res., July 1, 2008; 68(13): 5040 - 5048.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Kikuchi, H. Tsuda, K.-i. Kozaki, Y. Kanai, T. Kasamatsu, K. Sengoku, S. Hirohashi, J. Inazawa, and I. Imoto
Frequent Inactivation of a Putative Tumor Suppressor, Angiopoietin-Like Protein 2, in Ovarian Cancer
Cancer Res., July 1, 2008; 68(13): 5067 - 5075.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Engels, S. K. Knauer, S. Loibl, V. Fetz, P. Harter, A. Schweitzer, A. Fisseler-Eckhoff, F. Kommoss, L. Hanker, V. Nekljudova, et al.
NO Signaling Confers Cytoprotectivity through the Survivin Network in Ovarian Carcinomas
Cancer Res., July 1, 2008; 68(13): 5159 - 5166.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. S. Mitsiades, E. M. Ocio, A. Pandiella, P. Maiso, C. Gajate, M. Garayoa, D. Vilanova, J. C. Montero, N. Mitsiades, C. J. McMullan, et al.
Aplidin, a Marine Organism-Derived Compound with Potent Antimyeloma Activity In vitro and In vivo
Cancer Res., July 1, 2008; 68(13): 5216 - 5225.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Bonome, D. A. Levine, J. Shih, M. Randonovich, C. A. Pise-Masison, F. Bogomolniy, L. Ozbun, J. Brady, J. C. Barrett, J. Boyd, et al.
A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
Cancer Res., July 1, 2008; 68(13): 5478 - 5486.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. P. Worden, B. Kumar, J. S. Lee, G. T. Wolf, K. G. Cordell, J. M.G. Taylor, S. G. Urba, A. Eisbruch, T. N. Teknos, D. B. Chepeha, et al.
Chemoselection As a Strategy for Organ Preservation in Advanced Oropharynx Cancer: Response and Survival Positively Associated With HPV16 Copy Number
J. Clin. Oncol., July 1, 2008; 26(19): 3138 - 3146.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol, D. Niedzwiecki, B. Shank, T. A. Colacchio, J. Ellerton, F. Valone, S. Budinger, J. M. Day, J. Hopkins, J. Tepper, et al.
Induction Therapy for Poor-Prognosis Anal Canal Carcinoma: A Phase II Study of the Cancer and Leukemia Group B (CALGB 9281)
J. Clin. Oncol., July 1, 2008; 26(19): 3229 - 3234.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G. Giaccone and P. A. Zucali
Src as a potential therapeutic target in non-small-cell lung cancer
Ann. Onc., July 1, 2008; 19(7): 1219 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Gallo, G. F. Zannoni, I. De Stefano, M. Mosca, C. Ferlini, E. Mantuano, and G. Scambia
Soy Phytochemicals Decrease Nonsmall Cell Lung Cancer Growth In Female Athymic Mice
J. Nutr., July 1, 2008; 138(7): 1360 - 1364.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. H. M. A. Bartels, Y. M. van der Linden, and W. T. A. van der Graaf
Spinal Extradural Metastasis: Review of Current Treatment Options
CA Cancer J Clin, July 1, 2008; 58(4): 245 - 259.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. A. Sinicrope, R. L. Rego, N. R. Foster, S. N. Thibodeau, S. R. Alberts, H. E. Windschitl, and D. J. Sargent
Proapoptotic Bad and Bid Protein Expression Predict Survival in Stages II and III Colon Cancers
Clin. Cancer Res., July 1, 2008; 14(13): 4128 - 4133.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. P. Koivunen, C. Mermel, K. Zejnullahu, C. Murphy, E. Lifshits, A. J. Holmes, H. G. Choi, J. Kim, D. Chiang, R. Thomas, et al.
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Clin. Cancer Res., July 1, 2008; 14(13): 4275 - 4283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. F. McEntee, C. Ziegler, D. Reel, K. Tomer, A. Shoieb, M. Ray, X. Li, N. Neilsen, F. B. Lih, D. O'Rourke, et al.
Dietary n-3 Polyunsaturated Fatty Acids Enhance Hormone Ablation Therapy in Androgen-Dependent Prostate Cancer
Am. J. Pathol., July 1, 2008; 173(1): 229 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. C. Vinikoor, J. C. Schroeder, R. C. Millikan, J. A. Satia, C. F. Martin, J. Ibrahim, J. A. Galanko, and R. S. Sandler
Consumption of trans-Fatty Acid and Its Association with Colorectal Adenomas
Am. J. Epidemiol., June 27, 2008; (2008) kwn134v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Song, H. S. Sekhon, X. W. Fu, M. Maier, Y. Jia, J. Duan, B. J. Proskosil, C. Gravett, J. Lindstrom, G. P. Mark, et al.
Activated Cholinergic Signaling Provides a Target in Squamous Cell Lung Carcinoma
Cancer Res., June 15, 2008; 68(12): 4693 - 4700.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. R. Mallery, J. C. Zwick, P. Pei, M. Tong, P. E. Larsen, B. S. Shumway, B. Lu, H. W. Fields, R. J. Mumper, and G. D. Stoner
Topical Application of a Bioadhesive Black Raspberry Gel Modulates Gene Expression and Reduces Cyclooxygenase 2 Protein in Human Premalignant Oral Lesions
Cancer Res., June 15, 2008; 68(12): 4945 - 4957.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-W. Liu, J. K. Nagpal, W. Sun, J. Lee, M. S. Kim, K. L. Ostrow, S. Zhou, C. Jeronimo, R. Henrique, W. Van Criekinge, et al.
ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer
Clin. Cancer Res., June 15, 2008; 14(12): 3754 - 3760.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. F. Shariat, J. A. Karam, J. Walz, C. G. Roehrborn, F. Montorsi, V. Margulis, F. Saad, K. M. Slawin, and P. I. Karakiewicz
Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers
Clin. Cancer Res., June 15, 2008; 14(12): 3785 - 3791.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X.-R. Yang, Y. Xu, G.-M. Shi, J. Fan, J. Zhou, Y. Ji, H.-C. Sun, S.-J. Qiu, B. Yu, Q. Gao, et al.
Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection
Clin. Cancer Res., June 15, 2008; 14(12): 3850 - 3859.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G. Lurje, W. Zhang, A. M. Schultheis, D. Yang, S. Groshen, A. E. Hendifar, H. Husain, M. A. Gordon, F. Nagashima, H. M. Chang, et al.
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
Ann. Onc., June 11, 2008; (2008) mdn368v1.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. E.P. Prince and L. E. Ailles
Cancer Stem Cells in Head and Neck Squamous Cell Cancer
J. Clin. Oncol., June 10, 2008; 26(17): 2871 - 2875.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. R. Setlur, K. D. Mertz, Y. Hoshida, F. Demichelis, M. Lupien, S. Perner, A. Sboner, Y. Pawitan, O. Andren, L. A. Johnson, et al.
Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
J Natl Cancer Inst, June 4, 2008; 100(11): 815 - 825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. J. Duell, P. M. Bracci, J. H. Moore, R. D. Burk, K. T. Kelsey, and E. A. Holly
Detecting Pathway-Based Gene-Gene and Gene-Environment Interactions in Pancreatic Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1470 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
F. Shen, K. Shinohara, D. Kumar, A. Khemka, A. R. Simoneau, P. N. Werahera, L. Li, Y. Guo, R. Narayanan, L. Wei, et al.
Three-Dimensional Sonography With Needle Tracking: Role in Diagnosis and Treatment of Prostate Cancer
J. Ultrasound Med., June 1, 2008; 27(6): 895 - 905.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. Y. Bilimoria, C. M. Balch, D. J. Bentrem, M. S. Talamonti, C. Y. Ko, J. R. Lange, D. P. Winchester, and J. D. Wayne
Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States
Ann. Surg. Oncol., June 1, 2008; 15(6): 1566 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. Ra, E. C. Paulson, J. Kucharczuk, K. Armstrong, C. Wirtalla, R. Rapaport-Kelz, L. R. Kaiser, and F. R. Spitz
Postoperative Mortality After Esophagectomy for Cancer: Development of a Preoperative Risk Prediction Model
Ann. Surg. Oncol., June 1, 2008; 15(6): 1577 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
I. Esposito, J. Kleeff, F. Bergmann, C. Reiser, E. Herpel, H. Friess, P. Schirmacher, and M. W. Buchler
Most Pancreatic Cancer Resections are R1 Resections
Ann. Surg. Oncol., June 1, 2008; 15(6): 1651 - 1660.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. C. Zhu, T. D. Yan, and D. L. Morris
A Systematic Review of Radiofrequency Ablation for Lung Tumors
Ann. Surg. Oncol., June 1, 2008; 15(6): 1765 - 1774.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Farjah, D. E. Wood, D. Yanez III, R. G. Symons, B. Krishnadasan, and D. R. Flum
Temporal trends in the management of potentially resectable lung cancer.
Ann. Thorac. Surg., June 1, 2008; 85(6): 1850 - 1855.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
O. OKTEM and K. OKTAY
Preservation of Menstrual Function in Adolescent and Young Females
Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
American Journal of Men's HealthHome page
J. Jayachandran and S. J. Freedland
Prevention of Prostate Cancer: What We Know and Where We Are Going
American Journal of Men's Health, June 1, 2008; 2(2): 178 - 189.
[Abstract] [PDF]


Home page
Cancer Prevention ResearchHome page
M. Bhutani, A. K. Pathak, Y.-H. Fan, D. D. Liu, J. J. Lee, H. Tang, J. M. Kurie, R. C. Morice, E. S. Kim, W. K. Hong, et al.
Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs
Cancer Prevention Research, June 1, 2008; 1(1): 39 - 44.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Ganesan, T. Ivanova, Y. Wu, V. Rajasegaran, J. Wu, M. H. Lee, K. Yu, S. Y. Rha, H. C. Chung, B. Ylstra, et al.
Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel {beta}-Catenin/TCF Target Gene
Cancer Res., June 1, 2008; 68(11): 4277 - 4286.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Wang, D. T. Sloper, S. N. Addo, D. Tian, J. W. Slaton, and C. Xing
WL-276, an Antagonist against Bcl-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth
Cancer Res., June 1, 2008; 68(11): 4377 - 4383.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei
Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck
Cancer Res., June 1, 2008; 68(11): 4479 - 4485.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Shahani, M. Braga-Basaria, and S. Basaria
Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2042 - 2049.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. D. Myers, P. B. Jacobsen, Y. Huang, M. H. Frost, C. A. Patten, J. R. Cerhan, and T. A. Sellers
Familial and Perceived Risk of Breast Cancer in Relation to Use of Complementary Medicine
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1527 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. M. Watson, S. W. Miller, M. Fraig, D. J. Cole, D. K. Watson, and A. M. Boylan
CaSm (LSm-1) Overexpression in Lung Cancer and Mesothelioma Is Required for Transformed Phenotypes
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 671 - 678.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. D. Lewis, A. Winter, T. F. Murphy, S. Tripathi, V. N. Pandey, and B. E. Barton
STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends
Mol. Cancer Ther., June 1, 2008; 7(6): 1543 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
P. Lance and S. R. Hamilton
Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention
Cancer Prevention Research, June 1, 2008; 1(1): 4 - 8.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
N. Krieger
Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections
Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
F. L. Meyskens Jr., C. E. McLaren, D. Pelot, S. Fujikawa-Brooks, P. M. Carpenter, E. Hawk, G. Kelloff, M. J. Lawson, J. Kidao, J. McCracken, et al.
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Cancer Prevention Research, June 1, 2008; 1(1): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
J. P. van Meerbeeck, S. Meersschout, R. De Pauw, I. Madani, and W. De Neve
Modern Radiotherapy as Part of Combined Modality Treatment in Locally Advanced Non-Small Cell Lung Cancer: Present Status and Future Prospects
Oncologist, June 1, 2008; 13(6): 700 - 708.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. D. Michaelson, O. Iliopoulos, D. F. McDermott, F. J. McGovern, M. G. Harisinghani, and E. Oliva
Case 17-2008 -- A 63-Year-Old Man with Metastatic Renal-Cell Carcinoma
N. Engl. J. Med., May 29, 2008; 358(22): 2389 - 2396.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Jazdzewski, E. L. Murray, K. Franssila, B. Jarzab, D. R. Schoenberg, and A. de la Chapelle
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
PNAS, May 20, 2008; 105(20): 7269 - 7274.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. C. Siva, M. A. Wild, R. E. Kirkland, M. J. Nolan, B. Lin, T. Maruyama, F. Yantiri-Wernimont, S. Frederickson, K. S. Bowdish, and H. Xin
Targeting CUB Domain-Containing Protein 1 with a Monoclonal Antibody Inhibits Metastasis in a Prostate Cancer Model
Cancer Res., May 15, 2008; 68(10): 3759 - 3766.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Jia, J. R. Lupton, R. Smith, B. R. Weeks, E. Callaway, L. A. Davidson, W. Kim, Y.-Y. Fan, P. Yang, R. A. Newman, et al.
Reduced Colitis-Associated Colon Cancer in Fat-1 (n-3 Fatty Acid Desaturase) Transgenic Mice
Cancer Res., May 15, 2008; 68(10): 3985 - 3991.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Sargeant, R. C. Rengel, S. K. Kulp, R. D. Klein, S. K. Clinton, Y.-C. Wang, and C.-S. Chen
OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model
Cancer Res., May 15, 2008; 68(10): 3999 - 4009.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Yang, T. Sun, L. Wang, D. Yu, X. Zhang, X. Miao, J. Liu, D. Zhao, H. Li, W. Tan, et al.
Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer
Clin. Cancer Res., May 15, 2008; 14(10): 3230 - 3236.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. C. Hu, Q. Wang, C. L. Pashos, S. R. Lipsitz, and N. L. Keating
Utilization and Outcomes of Minimally Invasive Radical Prostatectomy
J. Clin. Oncol., May 10, 2008; 26(14): 2278 - 2284.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. F.G. de Maat, C. J.H. van de Velde, M. P.J. van der Werff, H. Putter, N. Umetani, E. M. Klein-Kranenbarg, R. R. Turner, J. H. J.M. van Krieken, A. Bilchik, R. A.E.M. Tollenaar, et al.
Quantitative Analysis of Methylation of Genomic Loci in Early-Stage Rectal Cancer Predicts Distant Recurrence
J. Clin. Oncol., May 10, 2008; 26(14): 2327 - 2335.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Wheatley-Price, K. Ding, L. Seymour, G. M. Clark, and F. A. Shepherd
Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
J. Clin. Oncol., May 10, 2008; 26(14): 2350 - 2357.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
H. J. Meulenbeld, L. N. van Steenbergen, M. L. G. Janssen-Heijnen, V. E. P. P. Lemmens, and G. J. Creemers
Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004
Ann. Onc., May 7, 2008; (2008) mdn176v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. M. Macias-Perez, R. Zent, M. Carmosino, M. D. Breyer, R. M. Breyer, and A. Pozzi
Mouse EP3 {alpha}, {beta}, and {gamma} Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis in Vivo
J. Biol. Chem., May 2, 2008; 283(18): 12538 - 12545.
[Abstract] [Full Text] [PDF]